Discontinued — last reported Q3 '19
An increase suggests higher potential future revenue from strategic partnerships, while a decrease may indicate a reduction in the scope or value of collaborative agreements.
This metric represents the total contract value or transaction price allocated to developmental, regulatory, and commerc...
Comparable to 'contingent consideration' or 'milestone payment potential' reported by other biotechnology and diagnostic firms in their licensing disclosures.
ntra_segment_developmental_regulatory_and_commercial_milestones_agreement_transaction_price